Ambit Hits A Triple, Signs BMS, GSK, Pfizer To Deals Jan. 24, 2005 Ambit Biosciences Inc.'s super-multi-tasking approach to kinase screening bagged the company deals with three of pharma's top players - Bristol-Myers Squibb Co., GlaxoSmithKline plc and Pfizer Inc. (BioWorld Today)Read More
RSS